The Impact of Graft-Versus-Host Disease on Survival in Children
with Non-Malignant Disorders Receiving Allogeneic Hematopoietic Cell
Transplant
Biljana Horn, MD1, Paul Castillo,
MD1, Mustafa Hanif1, Jorge Galvez
Silva, MD3, Edward Ziga, MD4, Warren
Alperstein, MD4, Michael Joyce, MD,
PhD5, John Fort, MD1, Gauri
Sunkersett, DO2, Benjamin Oshrine,
MD2, Jessica Cline, BS1, Fan Yang,
MS1, Jing Zhao, PhD.MS1 and Deepak
Chellapandian, MD MBBS2
Affiliations:
(1) University of Florida, Gainesville, FL
(2) Center for Cell and Gene Therapy for Non Malignant-Conditions, Blood
and Marrow Transplant Program, Cancer & Blood Disorders Institute,
Johns Hopkins All Children’s Hospital, St Petersburg, FL; (3) Nicklaus
Children’s Hospital, Miami, FL
(4) Pediatric Hematology and Oncology, University of Miami School of
Medicine, Miami, FL (5) Nemours Children’s Clinic and Wolfson Children’s
Hospital, Jacksonville, FL
Corresponding Author:
Email: Biljana Horn; e-mail:
Biljana.horn@ufl.edu,
1600 SW Archer Avenue, Gainesville, FL 32610
Phone (mobile) 415-215-6930, FAX:352 294 8091
Article Type: Research Article
Word Count: abstract 246
Word Count: main text 2571
Tables: 3, Figures: 2, References: 21, Supporting files: 0
Short Title: GVHD in Children with Non-Malignant Disorders
Key Words: GVHD, pediatric HCT, non-malignant disorders, Florida
consortium
Abbreviations used in the manuscript: